Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Adult Males

Background: Open label placebos with patient education are effective in reducing chronic pain, and recent studies on their effect on pain have established interest in this field. Nevertheless, data on their effect on acute pain are scarce, and on hyperalgesia and allodynia, absent. This study assessed the effect of open label placebos on acute pain in healthy adult males and the influence of placebo education. Methods: Thirty-two healthy males were included in this prospective, randomized, assessor-blinded crossover, single-center study assessing pain intensities (via numeric rating scale), area of hyperalgesia (von Frey filament), and allodynia (dry cotton swab) in a pain model utilizing intracutaneous electrical stimulation. The authors compared the effect of intravenous open label placebo on pain compared to no treatment. The authors further examined the effect of placebo on hyperalgesia and allodynia, and the influence of education (short vs. detailed) before placebo application. Saliva cortisol concentrations were also measured. Results: Pain ratings (median, first to third quartile) were 21% lower during placebo treatment compared to no treatment, 4.0 (3.2 to 4.9) versus 5.1 (4.7 to 5.4), respectively (P = 0.001). The areas of hyperalgesia and allodynia were lower during placebo treatment compared to no treatment (hyperalgesia, 30 cm2 [17 to 47] vs. 55 cm2 [42 to 68], P = 0.003; allodynia, 24 cm2 [11 to 39] vs. 45 cm2 [31 to 62], P = 0.007). This corresponds to reductions of 47%. The extent of placebo education had no effect on pain. Saliva cortisol decreased significantly over time and was under the limit of detectability in the majority of participants in postbaseline measurements in both treatment branches. Baseline cortisol was not associated with the placebo effect or strength applied of current to reach defined pain ratings. Conclusions: Open label placebos might play a role in multimodal analgesic concepts. Using a well-characterized electrical pain sensitization model in human volunteers, the effects of short versus detailed placebo educational protocols were measured. Open label placebo treatment reduced pain sensitization in the volunteers, but the extent of placebo education did not modify these responses.

[1]  R. Gabriel,et al.  State of the art opioid-sparing strategies for post-operative pain in adult surgical patients , 2019, Expert opinion on pharmacotherapy.

[2]  M. Schaefer,et al.  Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis , 2018, PloS one.

[3]  I. Kirsch,et al.  Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia , 2017, Pain.

[4]  H. Flor,et al.  Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain , 2017, Pain.

[5]  P. Donnan,et al.  Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis , 2017, BMC Nephrology.

[6]  S. M. Vambheim,et al.  A systematic review of sex differences in the placebo and the nocebo effect , 2017, Journal of pain research.

[7]  N. Roberts,et al.  Effects of placebos without deception compared with no treatment: A systematic review and meta‐analysis , 2017, Journal of evidence-based medicine.

[8]  L. Colloca,et al.  Nocebo and pain: an overview of the psychoneurobiological mechanisms , 2017, Pain reports.

[9]  J. Bruhn,et al.  Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti‐Inflammatory Drugs , 2017, Pain practice : the official journal of World Institute of Pain.

[10]  Christoph Werner,et al.  Trust in the health care professional and health outcome: A meta-analysis , 2017, PloS one.

[11]  I. Kirsch,et al.  Open-label placebo treatment in chronic low back pain: a randomized controlled trial , 2016, Pain.

[12]  J. Gurwitz,et al.  Safety of metamizole: a systematic review of the literature , 2016, Journal of clinical pharmacy and therapeutics.

[13]  P. Enck,et al.  Relieving pain using dose-extending placebos: a scoping review. , 2016, Pain.

[14]  T. Kaptchuk,et al.  Are Open‐Label Placebos Ethical? Informed Consent and Ethical Equivocations , 2016, Bioethics.

[15]  J. Micó,et al.  A review of chronic pain impact on patients, their social environment and the health care system , 2016, Journal of pain research.

[16]  M. Jensen,et al.  Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics , 2016, Pain.

[17]  K. Rentsch,et al.  Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial , 2016, Anesthesiology.

[18]  T. Kaptchuk,et al.  Placebo Effects in Medicine. , 2015, The New England journal of medicine.

[19]  Peter Kreiner,et al.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. , 2015, Annual review of public health.

[20]  F. Benedetti.  Placebo Effects: From the Neurobiological Paradigm to Translational Implications , 2014, Neuron.

[21]  E. Pogatzki-Zahn,et al.  Nonopioid analgesics for postoperative pain management , 2014, Current opinion in anaesthesiology.

[22]  H. Flor,et al.  Placebo analgesia: Clinical applications , 2014, PAIN®.

[23]  D. Hoaglin,et al.  Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks , 2014, Science Translational Medicine.

[24]  C. Hornuss,et al.  Evidence-based analysis of risk factors for postoperative nausea and vomiting. , 2012, British journal of anaesthesia.

[25]  M. Allard,et al.  Who Is at Risk for Postdischarge Nausea and Vomiting after Ambulatory Surgery? , 2012, Anesthesiology.

[26]  Lee S. Simon.  RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH , 2012, Military medicine.

[27]  F. Benedetti,et al.  Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors , 2011, Nature Medicine.

[28]  C. Woolf.  Central sensitization: Implications for the diagnosis and treatment of pain , 2011, PAIN.

[29]  I. Kirsch,et al.  Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome , 2010, PloS one.

[30]  Alban Latremoliere,et al.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity. , 2009, The journal of pain : official journal of the American Pain Society.

[31]  D. Drossman,et al.  Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome , 2008, BMJ : British Medical Journal.

[32]  Fabrizio Benedetti,et al.  A comprehensive review of the placebo effect: recent advances and current thought. , 2008, Annual review of psychology.

[33]  F. Benedetti,et al.  Opioid-Mediated Placebo Responses Boost Pain Endurance and Physical Performance: Is It Doping in Sport Competitions? , 2007, The Journal of Neuroscience.

[34]  P. McGettigan,et al.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.

[35]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[36]  Pierre Rainville,et al.  Direct Comparison of Placebo Effects on Clinical and Experimental Pain , 2006, The Clinical journal of pain.

[37]  Luana Colloca,et al.  Overt versus covert treatment for pain, anxiety, and Parkinson's disease , 2004, The Lancet Neurology.

[38]  S. Dickerson,et al.  Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. , 2004, Psychological bulletin.

[39]  Jürgen Schüttler,et al.  A New Model of Electrically Evoked Pain and Hyperalgesia in Human Skin: The Effects of Intravenous Alfentanil, S (+)-ketamine, and Lidocaine , 2001, Anesthesiology.

[40]  J. Tijssen,et al.  Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos , 2000, Journal of Neurology.

[41]  F. Benedetti,et al.  Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.

[42]  C. Kirschbaum,et al.  Salivary cortisol in psychoneuroendocrine research: Recent developments and applications , 1994, Psychoneuroendocrinology.

[43]  P. Sandroni,et al.  International association for the study of pain , 1986, Pain.

[44]  H. Fields,et al.  MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[45]  H. Fields,et al.  THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[46]  C. Welch,et al.  REDUCTION OF POSTOPERATIVE PAIN BY ENCOURAGEMENT AND INSTRUCTION OF PATIENTS. A STUDY OF DOCTOR-PATIENT RAPPORT. , 1964, The New England journal of medicine.

[47]  C. Lindsell,et al.  Randomized Controlled Trial , 2020, Encyclopedia of Behavioral Medicine.

[48]  C. Woolf,et al.  Towards a mechanism-based approach to pain diagnosis , 2016 .

[49]  H. Flor,et al.  Clinical and ethical implications of placebo effects: enhancing patients' benefits from pain treatment. , 2014, Handbook of experimental pharmacology.

[50]  C. King,et al.  Salivary cortisol and soluble tumor necrosis factor-α receptor II responses to multiple experimental modalities of acute pain. , 2012, Psychophysiology.

[51]  K. Wiech,et al.  Supplementary Materials for The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil , 2011 .

[52]  E. Aardal,et al.  Cortisol in Saliva - Reference Ranges and Relation to Cortisol in Serum , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.